DR

David Rosenbaum

Global Medical Head of Dyslipidemia

David Rosenbaum is currently a Business Unit Director in Vaccine & Immune Therapies at AstraZeneca France, leading a team of 20 individuals. Previously, David served as the Cardiovascular, Renal, and Metabolism Medical Director and Acting Medical Affairs Director at AstraZeneca, overseeing a team of 30. With a robust academic background that includes an MD, a PhD in Cardiovascular Physiology and Pharmacology, and an Executive MBA from INSEAD, David has spent a decade in academia as an Associate Professor at Pitié Salpêtrière Hospital. Additionally, David has demonstrated entrepreneurial skills by creating a smartphone app and building innovative teams in healthcare.

Location

United States

Links


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices